Please assess the completion status of the following clinical trial:

Trial Title: A PK and Safety Study in Subjects With Hepatic Impairment

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Moderate or severe hepatic impairment or matched control~* BMI between 18.0 and 40.0 kg/m2~Exclusion Criteria:~* Evidence of acute deterioration of hepatic function within 8 weeks~* ALT or AST ≥ 5 times upper limit of normal for moderates; ALT or AST ≥ 8 times upper limit of normal for severes~* Total bilirubin \> 5 mg/dl for moderates; no upper limit for severes~* Hemoglobin \< 10g/dl for moderates; Hemoglobin \< 9g/dl for severes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Moderate hepatic (Type: EXPERIMENTAL): None
- Severe Hepatic (Type: EXPERIMENTAL): None
- Matched control (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).